Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

BACKGROUND—In many transplant centres lamivudine is an important component of prophylaxis against, and treatment of, hepatitis B virus (HBV) graft infection. Drug resistant HBV species with specific polymerase mutations may emerge during lamivudine treatment.
AIMS—To examine the clinical consequence...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mutimer, D, Pillay, D, Shields, P, Cane, P, Ratcliffe, D, Martin, B, Buchan, S, Boxall, L, O'Donnell, K, Shaw, J, Hubscher, S, Elias, E
Format: Artigo
Idioma:Inglês
Publicat: 2000
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1727773/
https://ncbi.nlm.nih.gov/pubmed/10601065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.46.1.107
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars